Prevalence and Associated Factor of Meningococcal Carriers of Indonesian Umrah Pilgrims Authors: Maria Lawrensia Tampubolon, Vivi Setiawaty, Verawati Sulaiman, Teguh Sarry Hartono, Siti Maemun, Tri Yuli Setianingsih, Aninda Dinar Widiantari, Nadia Humaira, Rofiud Darojat, Arni Sulistia, Rustika Rustika, Armedy Ronny Hasugian, Harimat Hendarwan Published: 2026 ABSTRACT AbstractBackgroundMeningococcal meningitis (MM) cases are increasing in 2024. The infection spread widely during mass gatherings, including religious activities like Umrah. In 2023, the total number of Indonesia’s Umrah pilgrims was 1.2 million people, much larger than the Hajj pilgrims (209.782 people). Thus, it is estimated that the number of meningococcus carriers also increased. Besides, there is no surveillance system for the Umrah pilgrimage to prevent Neisseria meningitidis from entering the country. The conducted study aimed to describe the proportion of meningococcal carriers among Indonesian Umrah pilgrims and their associated factors.MethodsThe study was cross-sectional among the Umrah pilgrims who arrived via Soekarno-Hatta International Airport and Juanda International Airport. A self-administered questionnaire was sent to each participant and validated at arrival. An oropharyngeal swabs and blood draws (only if symptoms were present) were obtained. RT-PCR examinations were performed to identify N. meningitidis.ResultsThe study enrolled 900 pilgrims with a mean age of 51.34 ± 12.98 (17–79), with 50.9% female. Nearly 9.5% of pilgrims declared having a comorbid disease, and 100% had been vaccinated. N. meningitidis was detected in 201 participants (22.3%) in oropharyngeal swabs as indicator of transmission potential and the need for surveillance.ConclusionsThe analysis data showed that marital status and timing of meningococcal vaccine significantly correlate with meningococcal Carrier. Meningitis surveillance must be done routinely and systematically to decrease the risk of the disease.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1007/s44197-026-00630-y.Keywords: Meningococcal Carrier, Meningitis Vaccination, Neisseria meningitidis, Transmission, Umrah Pilgrims Introduction Meningococcal meningitis (MM) is the most common/important manifestation within Invasive Meningococcal Disease (IMD). Meningococcal meningitis (MM) can be fatal, particularly in young children, though severe cases can occur in individuals of all age groups. It’s important to note that while the burden of mortality is often higher in younger children, the highest case fatality rates are typically seen in those aged 15 and older. Additionally, the methods section of this study focused on adults; it might be worthwhile to consider the implications of fatal diseases in adults as well [1, 2]. MM is characterized by infection or inflammation of the membranes, called the meninges, which surrounding the brain and spinal cord, caused by Neisseria meningitidis (meningococcus) [3]. The agents are transmitted through respiratory droplets and close contact with respiratory secretions from an infected person [4–6]. Asymptomatic oronasopharyngeal carriage is the main reservoir and source for transmission [7]. The case fatality rate ranges between 10 and 14%, and the highest in adolescents and adults (≥ 15 years) reached 20%. Out of individuals who survive meningococcal disease, 10–19% experienced lifelong sequelae, including limb and digit amputation, neurological impairment, hearing loss, and renal failure [8]. MM is considered a potential event of concern due to its high transmission. The dynamics of meningococcal carriage are highly variable and influenced by age, social behavior, and environmental factors. Globally, nasopharyngeal or oropharyngeal carriage of N. meningitidis peaks in adolescents and young adults (approximately 23.7%), serving as the primary source of horizontal transmission within communities [9]. While the majority of carriers remain completely asymptomatic, a subtle shift in host immunity, viral co-infections, or microenvironmental changes in the respiratory tract can trigger the invasion of the mucosal barrier, leading to rapid disease progression [10]. Meningococcal disease occurs worldwide as an endemic infection, particularly in the African meningitis belt area [11–13]. Sudan and Saudi Arabia have a high prevalence of serogroup A disease and have witnessed outbreaks of serogroup W-135 during recent Hajj seasons [14]. In 2024, there was an increasing number of confirmed cases in Niger and the USA [15]. Sudan and Saudi Arabia have a high prevalence of serogroup A disease and have witnessed outbreaks of serogroup W-135 during recent Hajj seasons. According to the WHO, during epidemiological weeks 51 and 52 of 2024, confirmed cases of meningococcal meningitis (MM) were reported in Australia (2 cases), Mongolia (1 case), and the United States (7 cases). In contrast, many countries in Southeast Asia lack sufficient surveillance data to accurately determine the incidence of MM, although outbreaks have been reported among travelers returning from Hajj and Umrah [13, 16]. Handayani studied meningococcal carriers in Hajj pilgrims in Indonesia. She stated that between 1993 and 2003, it ranged from 0.9 to 11% [17]. Mass gatherings, such as the Hajj and Umrah pilgrimages, represent unique epidemiological challenges that significantly amplify the transmission networks of respiratory pathogens. The convergence of millions pilgrims from diverse geographical regions, combined with crowded accommodations, shared transport, and intense physical exertion, facilitates close and prolonged contact [18]. These conditions accelerate the acquisition and cross-transmission of hyper-invasive meningococcal strains among historically naive populations [19, 20]. Consequently, international religious gatherings have historically been the epicenters for multinational outbreaks of serogroups A and W-135 [21–23]. The threat of meningococcal disease extends beyond the borders of the Kingdom of Saudi Arabia; returning pilgrims frequently act as vectors for domestic transmission. Upon returning to their home countries, asymptomatic carriers unknowingly introduce acquired strains to household contacts and local communities, potentially causing secondary clusters of invasive meningococcal disease (IMD) in regions with low herd immunity [21–23]. This underscores the critical need for robust post-arrival surveillance, particularly for Umrah pilgrims who currently avoid the strict longitudinal health monitoring frameworks applied to Hajj pilgrims. Data from the Indonesian Ministry of Health from 2005 to 2010 showed that overall meningitis cases in Indonesia reached 19,381 people and 1,025 (5.2%) fatality cases. Compared to the number of Indonesian Hajj Pilgrims (± 220.000 pilgrims in 2023), Umrah pilgrims are potentially has greater risk of spreading or transmission Meningococcus. Data from the Computerized System for Integrated Management of Umrah and Hajj (Siskopatuh) of the Ministry of Religious Affairs of the Republic of Indonesia stated that the number of Umrah pilgrims in 2023 increased rapidly, reaching 1.2 million people. Most pilgrims came from West Java (171,275 people), East Java (160,977 people), and Jakarta Greater Area (124,999) people [24]. There is limited information on the prevalence of meningococcal carriage among Hajj and Umrah pilgrims, although Indonesia is one of the countries with the largest number of pilgrims. As the number of higher Umrah pilgrims increases, the risk of transmission of MM in Indonesia will also increase. Meningococcal meningitis surveillance on Indonesian Hajj pilgrims has been carried out regularly, but not on Umrah pilgrims. Health surveillance on Hajj pilgrims includes comprehensive health examinations (also called istitho’ah), obligatory meningococcal vaccine, and health supervision during the journey (including for IMD). These activities are reported under Information System and Integrated Hajj Computerization (Sistem Informasi dan Komputerisasi Haji Terpadu /SISKOHAT). In contrast to the health system for Hajj pilgrims, the system for Umrah pilgrims is not well-developed [25]. Previous research studied meningococcal carriers in pilgrims who had completed the Hajj pilgrims [26]. A study conducted at King Abdulaziz International Airport evaluated three different pilgrim populations. Among 1,055 Hajj pilgrims screened upon arrival, 36 (3.4%) tested positive for nasopharyngeal carriage of Neisseria meningitidis. Among 373 pilgrims screened at departure, 6 (1.61%) tested positive for N. meningitidis. In addition, 628 pilgrims underwent nasopharyngeal swabbing at both departure and arrival; of these, 36 (5.7%) tested positive for N. meningitidis upon arrival, while 16 (2.5%) remained positive after Hajj [27]. Meanwhile, no previous study has investigated meningococcal Carrier among Umrah pilgrims in Indonesia. This study aims to determine the prevalence and associated factors of carriers of N. meningitidis in Umrah pilgrims. It also describes the demographics, symptoms, clinical manifestations, associated factors, and examination of N. meningitidis in Umrah pilgrims. Methods Study Design A cross-sectional study was conducted in Indonesia on 900 Umrah pilgrims who arrived via Soekarno Hatta International Airport in Jakarta and Juanda International Airport in Surabaya. Study Population The participants were 900 Umrah pilgrims gathered by purposive sampling at specific flight that was approved by Ministry of Religious Affair. Its local office in Jakarta and Surabaya then gave a list of potential Umrah Tour Agencies to get the participants. If the Umrah Tour Agencies approved the idea of the study and willing to participate, we arranged the samples collection. We enrolled Umrah pilgrims aged 17–80 years who were willing to participate in the entire protocol. This process began with a self-reported questionnaire and an oropharyngeal swab. Additionally, participants agreed to a blood draw if they developed symptoms during travel. We made a validation after arriving in Airport. We informed the study participants before departing for Saudi Arabia. Participants filled out an online questionnaire two days before departure to Indonesia. The oropharyngeal swab was taken at the port health office after passenger had disembarked from the aircraft but before they reached the immigration counter, and if the participant experienced symptoms, blood was drawn. The participants were not asked about mouthwash using. Sample To calculate the research sample size, the Slovin formula for a single population proportion with a limited population correction was utilized, based on the following assumptions: n = required sample size, Z = critical value for normal distribution at a 95% confidence level (1.96), d = 0.01 (1% margin of error), and the population proportion from a previous study [28] =1.3%, yielding a required sample size of 450 participants per location. The sample size for Umrah pilgrims from Soekarno-Hatta Health Quarantine Office was 450 individuals, and the number of participants at Surabaya Health Quarantine Office was 450 individuals. Thus, the total number of participants across all sites was 900. Study Variables Study variables consist of Sociodemography (age, sex, Level of Education, Marital Status, Occupation, Health Insurance); risk factor (smoking, Meningococcal Vaccine before departing, Number of People in a Shared Room in the pilgrimage, Pre-Umrah Influenza Like-Illness (ILI) Symptoms, Days of Journey (counted from day of departure to arrival), Activity other than Umrah (culinary or/and pilgrimage or/and visiting sites, tour or/and shopping), and Comorbid Disease (stroke or/and diabetes mellitus or/and renal dysfunction or/and liver dysfunction or/and anemia or/and cancer or/and HIV or/and autoimmune disease); symptoms presentation during travel such as fever, defined as body temperature measurement by non-contact infrared thermometer ≥ 38̊, fever or a history of fever, and one of the symptoms was headaches, myalgia, cough, sore throat, photophobia, vomiting, diarrhea, rash); physical examinations (Blood Pressure, Body temperature, Heart rate, and Oxygen Saturation); laboratory result (RT-PCR N. meningitidis from oropharyngeal swab and blood). Meningococcal carrier is defined as an participants with oropharyngeal colonization by Neisseria meningitidis, confirmed by RT PCR method without symptomatic or symptomatic but negative blood RT-PCR. We categorized meningococcal carrier, yes meningococcal or no meningococcal carrier. Collecting Data The recruitment period started from October 5th to December 9th, 2024. The collection of subjective and objective data, as well as specimen sampling, involved port health officers. Subjective data enumerators were epidemiologists, doctors, nurses, who conducted physical examinations, and laboratory analysts who performed oropharyngeal swabs and blood sampling. The research team trained all personnel. Sociodemographic data, symptoms, and risk factors were obtained from participants’ self-reports through a questionnaire developed specifically for this study (Supplementary Material) and administered to those who provided informed consent. Subsequently, enumerators recorded the physical examination findings in the same anonymized questionnaire. RT-PCR was performed on both oropharyngeal swab and blood samples to detect Neisseria meningitidis using the Bioneer AccuPower N. meningitidis RT-PCR Kit (K-6845). Samples Collection and Storage Oropharyngeal swab was decided due to some reasons, such as higher bacterial density found in the posterior pharyngeal mucosa, alongside better tolerability for large-scale population studies. The swab and blood samples from all participants /Umrah pilgrims were collected at the Soekarno–Hatta and Surabaya Health Quarantine Office (n = 900). Blood samples was drawn to identify meningocemia only in symptomatic participants (n = 96). Both swab and blood samples were taken in the same day at arrival. Oropharyngeal swab samples were inserted into Copan eNAT medium (medium transport that contains Guanidine thiocyanate, Tris-EDTA, HEPES, and detergent) and placed in a refrigerator at 2–8 °C before sent to the Biomolecular Laboratory of Prof. Dr. Sulianti Saroso Infectious Diseases Hospital for further examination. Whole blood samples collected from Umrah pilgrims in EDTA tubes were transferred into cryotubes and stored at 2–8 °C until shipment. Before transportation, the samples were packaged using a triple-packaging system. Each sample was first sealed in a biohazard bag as the primary container, followed by placement in a cool box or Styrofoam container with ice gel packs to maintain the transport temperature between 2 and 8 °C. When a Styrofoam container was used, it was further enclosed in a cardboard box to provide additional protection during transportation. Sample delivery is done within a maximum of two days after collection and sent periodically to the Biomolecular Laboratory of Prof. Dr. Sulianti Saroso Infectious Diseases Hospital for further examination. Laboratory Analysis A total of 200 µl of samples was extracted using the Bioneer AccuPrep Genomic DNA Extraction Kit, cat.no.K-3032-G according to the protocol. ±50 µl of extraction eluent was obtained and stored in a -80 °C freezer. Real-Time PCR was performed using the Bioneer AccuPower Neisseria meningitidis Real-Time PCR Kit, cat no.K-6845. This PCR kit contains components such as 2.5 U Taq DNA Polymerase, dNTPs (dATP, dCTP, dGTP, dTTP), correction buffer with 2 mM MgCl2, and 0.4 µM of each primer and probe. A total of 7.5 µl of DNA template was added to 17.5 µl of PCR reaction mix, giving a total volume of 25 µl for each reaction. The kit targeted a region within the IS30 family transposase gene of Neisseria meningitidis. Positive control from the kit and negative control were included in the PCR reaction. PCR was performed on a Bioneer Exicycler™ 96 machine with the following protocol details: pre-denaturation for 5 min at 95 °C with 1 cycle, denaturation for 10 s at 95 °C with 45 cycles, annealing and extension for 20 s at 55 °C with 45 cycles. The interpretation of the PCR results is based on the formation of a sigmoid curve, negative results being characterised by the absence of sigmoid curve formation, positive results by CT (Cycle Threshold) values less than 32, and negative results by CT (Cycle Threshold) values greater than or equal to 32. Statistical Analysis Univariate analysis will compute the frequencies and percentages of Neisseria meningitidis carriage, symptoms, and RT-PCR positivity. Evaluated variables comprise sociodemographic data (sex, age, education, marital status, occupation, insurance) and clinical-epidemiological factors (comorbidities, smoking, vaccination, roommates, camel contact, prior respiratory infections, travel duration, activities other than umrah). Pearson’s chi-square test will evaluate the associations between clinical factors, risk exposures, and N. meningitidis positivity (p < 0.05). To avoid risk overestimation typical of logistic regression in cross-sectional studies with a high outcome prevalence (> 10%), a modified Poisson regression with robust variance will be utilized. Results will be reported as Prevalence Ratios (PRs) with 95% confidence intervals (p < 0.05). Results There were 2134 Umrah pilgrims who were informed about the study, and 937 completed the questionnaire. Thirteen people refused to participate, 20 were excluded due to age limitations, and 4 others were excluded because they were unwilling to have their blood drawn (Fig. 1). Nine hundred participants were enrolled in this study via the Soekarno Hatta Port Health Office (232 people) and the Juanda Port Health Office (668 people). Participant Flow Chart There were 804 participants without symptoms, and 96 people had their blood drawn because, during travel, they experienced fever or a history of fever plus one of the following symptoms: headaches, myalgia, cough, sore throat, photophobia, vomiting, diarrhea, or rash. Figure 1 describes the flow of participant recruitment. Traveling abroad and mass gatherings during the Umrah pilgrimage remain the primary risk factors for MM transmission. The study was conducted from October 5th to December 9th, 2024, which coincided with the peak Umrah travel season, as it overlapped with the end-of-year holidays. Laboratory results showed that 201 (22.3%) were meningococcal carriers, and none of them experienced meningocemia (Fig. 2). Most participants were female (Fig. 3). The average age was 51.34 ± 12.98 (17–79) years old. According to Indonesia’s Health Ministry, the population at risk above 60 years old accounted for 263 people (29,2%) (Fig. 4). Most participants had graduated from primary and secondary education; over half were actively working (n = 531, 59%). Meningococcal Carrier Status Meningococcal Carrier Status by Sex Meningococcal Carrier Status by Age Group Table 1 shows the risk factors and comorbid diseases of the participants. The participants had been on the journey for 12.8 ± 3.0 (9–18) days. Most participants declared themselves non-smokers. Comorbid diseases were experienced by 85 people (9.4%), including stroke (n = 5;0.6%), diabetes mellitus (n = 44;4.9%), chronic kidney disease (n = 4;0.4%), HIV/AIDS (n = 1;0.1%), chronic heart failure (n = 5;0.6%), and hypertension (n = 39;4.3%); each person might experience more than one disease. Pre-Umrah influenza-like-illness (ILI) symptoms are described as fever, cough, and sore throat fourteen days before departing to Saudi Arabia. Table 1Bivariate Analysis on the Background of Meningococcal CarriersVariableTotal (n = 900)Meningococcal CarrierP valueCarrier Meningococcus (n = 201)Non-Carrier Meningococcus (n = 699)DemographyLevel of Education0.184 No formal education621422.58%4877.42% Primary and secondary education4759520.00%38080.00% University-higher education3639225.34%27174.66%Marital Status0.025 Married73517523.81%56076.19% Single, widow or widower1652615.76%13984.24%Occupation0.695 Yes53112122.79%41077.21% None3698021.68%28978.32%Health Insurance0.133 None1673017.96%13782.04% Yes73317123.33%56276.67%Risk Factors Smoking0.101 Current Smoker1101614.55%9485.45% Past Smoker22627.27%1672.73% Never Smoke76817923.31%58976.69%Meningococcal Vaccine (before departing)0.144 < 2 weeks1532918.95%12481.05% 2–4 weeks52811321.40%41578.60% >4 weeks-3 months1804625.56%13474.44% >3–6 months7114.29%685.71% >6 months321237.50%2062.50%Number of People in a Shared Room in the pilgrimage (people)0.453> 540717.50%3382.50%≤ 586019422.56%66677.44%Pre-Umrah ILI Symptoms0.303 Yes791417.72%6582.28% No82118722.78%63477.22%Days of Journey (days)0.307 >143918120.72%31079.28% 9–1450912023.58%38976.42%Activity other than Umrah0.541 Yes4389421.46%34478.54% None46210723.16%35576.84%Comorbid disease0.414 Yes851618.82%6981.18% None81518522.70%63077.30%Symptoms and Clinical ManifestationHistory of Fever during Umrah0.695 Yes36925.00%2775.00% No86419222.22%67277.78%Fever0.799 Yes711521.13%5678.87% No82918622.44%64377.56%Headache0.015 Yes6169.84%5590.16% No83919523.24%64476.76%Myalgia0.073 Yes61813.11%5386.89% No83919323.00%64677.00%Cough0.302 Yes2595220.08%20779.92% No64114923.24%49276.76%Sore Throat0.42 Yes441227.27%3272.73% No85618922.08%66777.92%Photophobia0.061 Yes1200.00%12100.00% No88820122.64%68777.36%Vomiting0.188 Yes600.00%6100.00% No89420122.48%69377.52%Diarrhea0.608 Yes5120.00%480.00% No89520022.35%69577.65%Skin rash0.034 Yes7114.29%685.71% No89320022.40%69377.60%Symptoms Presented0.034 Yes3215918.38%26281.62% No57914224.53%43775.47% Bivariate Analysis on the Background of Meningococcal Carriers Clinical manifestations were included in the questionnaire. Thus, they were subjective according to participants’ recognition. Table 2 describes the clinical manifestation at arrival. Laboratory results showed that 201 (22.3%) were meningococcal carriers, and none of them experienced meningocemia. Table 2Analysis Multivariate on Risk Factor of Meningococcal CarrierVariableP; aPR (95% CI)Meningococcal Vaccine (before departing) < 2 weeksReference 2–4 weeks0.670; 1.08 (0.75–1.56) >4 weeks-3 months0.159; 1.34 (0.89–2.01) >3–6 months0.733; 0.75 (0.11–5.08) >6 months0.045; 1.77 (1.01–3.09)Smoking Current Smoker0.123; 0.53 (0.23–1.19) Past SmokerReference Never Smoke0.664; 0.86 (0.43–1.71)Marital Status0.023; 0.64 (0.44–0.94) Analysis Multivariate on Risk Factor of Meningococcal Carrier Table 1 also categorizes age according to the Minister of Health Regulation about Hajj Pilgrimage Health. Pearson analysis shows that each category has the same potential for meningococcal carriage. The same results were observed across sex, level of education, occupation, and health insurance ownership. Both married and single individuals, as well as widows and widowers, have the potential to be meningococcal carriers, although married people appear to have a higher chance (p < 0.05). In the associated factors category, the Carrier and non-Carrier groups describe less than 15% of participants as active smokers. According to the Pearson Test, the time of the meningococcal vaccine is correlated to meningococcal carrier (p < 0.05). Table 1 shows that the headache, skin rash, and symptoms presented are associated with the carriage. The Poisson Regression robust variance test was used to run a multivariate analysis and described three variables that significantly correlate with meningococcal Carrier: meningococcal vaccine and marital status but smoking as confounding variable. Participants who received the meningitis vaccine more than six months before departure were 1.77 times more likely to become carriers of meningitis compared to those who received the vaccine less than two weeks before departure (p = 0.045; PR: 1.77; 95% CI: 1.01–3.09). Carriage prevention is not complete, and waning immunity may occur. Only smoking was a confounding variable. Discussion This study showed 201 subjects (22.3%) were meningococcal carriers. This finding reveals a higher rate than a previous study. A cohort study among Umrah pilgrims in the Kingdom of Saudi Arabia (KSA) reported a meningococcal Carrier rate of 5.7% [26]. Wilder-Smith noted 1.3% lower rate than Hajj pilgrims (17%) in Singapore [29]. The high Carrier rate observed in this study aligns with research indicating that Indonesia, categorized as a low- and middle-income country (LMIC), has a higher rate of meningococcal infection (0.015–82%) compared to high-income countries (0.002–40%) [30]. A retrospective analysis by Handayani of Indonesian Hajj pilgrims from 1993 to 2003 also showed a high meningococcal meningitis Carrier (1.3–9.4%), underscoring the need for pre-departure health screening and interventions [17]. This study shows that 81.7% of Umrah pilgrims are married. These findings align with a previous study, which reported that 87% of participants were married, while the remaining 13% were unmarried [26]. This impacts the bivariate analysis, showing that 175 individuals were carriers. However, caution is needed when interpreting this data, as the higher proportion of married pilgrims likely skews the results, with fewer unmarried participants being detected due to their smaller representation. Although most participants are married, it cannot be confirmed whether these married pilgrims traveled with their spouses, as the study did not inquire about this aspect. It is possible that some pilgrims traveled alone without their partners. Close contact among family members has been associated with the transmission of Neisseria meningitidis [31]. However, marital status itself is not considered an independent factor associated with meningococcal transmission. Therefore, both married and unmarried individuals may have a similar potential to become meningococcal carriers. This study showed that non-smokers (85.3%) were more prevalent than smokers (12.2%) or former smokers (2.5%). This influenced the bivariate analysis, indicating a higher rate of carriers among non-smokers than smokers or former smokers. More than half of the subjects (589 out of 900) who were non-smokers were identified as non-carriers. Smoking was associated in bivariate analysis (if true), but not independently in multivariable analysis. Previous studies have highlighted the association between smoking and meningococcal Carrier among Hajj pilgrims [27, 29, 31, 32]. Plotkin stated that exposure to tobacco smoke alone could also increase the risk of being a carrier [33]. A previous study showed a significant increase in meningococcal carriers in high-density situations, such as mass gatherings (including Umrah and Hajj) that included room sharing with many people. Meningococcal vaccination (covering serogroups A, C, W, and Y) is a critical measure to reduce the risk of carriage [32]. Other studies emphasize the importance of vaccination as a protective factor for MM, even though it does not eliminate the possibility of becoming a carrier [34]. Our results supported this hypothesis, where high meningococcal carriage was found. In meningococcal meningitis, older children and adults will present main symptoms: headache, fever, neck stiffness, and altered mental status [7]. In this study, headache symptoms for meningococcal carriers were 9.84% (n = 61), as significantly associated with carriage [7]. Our study found that Umrah pilgrims who had received meningococcal shots more than six months before departing had a higher risk of becoming meningococcal carriers. Therefore need strengthening meningococcal vaccine policy among Umrah pilgrims, such as the vaccine should be given more than 14 days and less than 6 months before departure. According to health policy from Indonesia and Kingdom of Saudi Arabia (KSA), the meningococcal vaccine should be given no less than ten days before departing to KSA [35]. The meningococcal vaccine currently available in Indonesia is a polysaccharide vaccine produced by a national manufacturer. Conjugate vaccines is imported vaccines, have limited availability, and are administered primarily to children. Therefore, the type of meningococcal vaccine was not included as a variable in this study. Findings from a study on the timeliness of meningococcal meningitis vaccination among prospective Umrah pilgrims at the Pontianak Port Health Office from 2016 to 2018 revealed that compliance was related to knowledge, attitudes, and exposure to information but unrelated to health conditions or travel agency support [36]. Although vaccination is considered an important measure to prevent bacterial transmission, previous studies [26, 31] have reported inconsistent findings regarding vaccine effectiveness due to the lack of valid vaccination documentation and the inappropriate timing of vaccine administration. The Saudi Arabian government requires all pilgrims to receive the quadrivalent meningococcal vaccine at least 10 days before undertaking the Hajj pilgrimage (Alasmari, 2021) [26]. A single dose of the meningococcal vaccine is administered to prospective Hajj and Umrah pilgrims 10 to 14 days before departure. Meningococcal vaccination should be given at least 10–14 days prior to travel to allow sufficient time for the development of protective antibody levels. This recommendation is based on the fact that the immune response to the vaccine typically begins to develop within 5–7 days, while full protective immunity against meningococcal infection may take up to one month after vaccination (WHO, 2018; CDC, 2024) [35–37]. Therefore, administering the vaccine too close to the departure date may reduce its effectiveness in protecting pilgrims against the risk of meningococcal infection during the pilgrimage. In this study we found that there was no meningocemia in symptomatic meningococcal carrier. This can describe that vaccination is effective in preventing the development of meningococcal carrier into disease. Consistent with the findings of Alasmari et al., the Saudi Arabian government mandates that all pilgrims receive the quadrivalent meningococcal vaccine at least 10 days before departure [26, 37], The World Health Organization (WHO) also emphasizes the importance of ensuring that pilgrims receive the vaccine sufficiently in advance before entering areas with a high risk of transmission. The quadrivalent meningococcal vaccine is designed to protect against Neisseria meningitidis serogroups A, C, W, and Y, which have frequently been associated with outbreaks among Hajj and Umrah pilgrims. Furthermore, Memish et al. (2014) reported that adherence to the recommended vaccination schedule is essential for preventing meningococcal carriage and reducing transmission during mass gatherings [34]. Therefore, timely administration of the meningococcal vaccine not only supports public health policies but also provides optimal protection for pilgrims throughout their journey. Data on medical treatment during the Umrah was not collected. In the Umrah Health Regulation in Indonesia, there was no prophylaxis antibiotic recommendation for MM. Antibiotic use in KSA couldn’t be accessed freely, especially for travellers. A previous study noted that large crowds and frequent physical contact during Hajj and Umrah rituals increase the risk of transmission, both as carriers and as individuals who develop symptoms of meningitis [26, 31]. This study supported the current regulation that requires meningococcal vaccination before the Umrah pilgrimage. Individuals with higher education levels may better understand and manage health risks during the Umrah pilgrimage. Education level is also linked to socioeconomic status, influencing access to healthcare services and medical treatment. Those with higher education are likely to have better access to pre-departure vaccinations and information on preventive measures. The importance of education in managing the risks of infectious diseases underscores the relevance of this factor in global health prevention strategies, particularly among Hajj and Umrah populations. Higher education can enhance an individual’s understanding of the significance of vaccinations and other preventive measures [26, 38]. Our study has several limitations. The cross-sectional study design and the enrolment strategy, including the potential for volunteer bias, limit the generalizability of our findings and ability to establish causal relationships between the identified factors and meningococcal carrier. Second, the use of purposive sampling may introduce selection bias, potentially affecting the representativeness and generalizability of the results to all Indonesian Umrah pilgrims. In addition, we used a questionnaire to collect data; therefore, the responders obtained were prone to information bias. Some additional data, such as travel with family members, could enrich our findings. Serogroup analysis had been performed by a PCR multiplex procedure, but the serogroup identification examination was not optimal, even though this study can still describe meningococcal carrier data in Indonesia. Meningococcal serogroups assess the potential effectiveness of current vaccination strategies against the detected strains determined. The use of RT-PCR for detection of Neisseria meningitidis may identify bacterial DNA from both viable and non-viable organisms, which could lead to meningococcal carrier prevalence. The importance of health promotion among Umrah pilgrims in managing the risks of infectious diseases underscores the relevance of this factor in global health prevention strategies. This is particularly critical for populations traveling in large numbers, such as Umrah pilgrims. We recommend future studies cohort design, probability sampling, comprehensive serogroup analysis, and meningococcal antibody response would provide a more complete understanding of meningococcal carrier dynamics among Umrah pilgrims. Conclusion In conclusion, we found higher meningococcal Carrier among Umrah pilgrims than in Hajj in Indonesia. Associated factors for meningococcal carriers were marital status and the time of meningococcal vaccination. Umrah pilgrims receiving the meningococcal vaccine more than six months before departing have a more significant risk of becoming meningococcal carriers. Supplementary Information Supplementary Material 1. Supplementary Material 2. Acknowledgements We also extend our thanks to PT Bio Farma (Persero), the Directorate General of Disease Control of the Ministry of Health, Soekarno–Hatta Health Quarantine Office, Surabaya Health Quarantine Office, National Research and Innovation Agency, and the Ministry of Religious Affairs of the Republic of Indonesia, whose assistance was instrumental in this research. Authors’ Contributions Maria Lawrensia Tampubolon: Conceptualization, Supervision, Validation, Resources, Writing – review and editing. Vivi Setiawaty: Supervision. Verawati Sulaiman: Data curation, Validation, Supervision. Teguh Sarry Hartono: Data curation, Validation, Supervision. Siti Maemun: Data curation, Formal analysis, Methodology. Tri Yuli Setianingsih: Data curation, Validation. Aninda Dinar Widiantari: Data curation, Validation, Project administration. Nadia Humaira: Data curation, Validation, Project administration. Rofiud Darojat: Data curation, Resources. Arni Sulistia: Data curation, Resources. Rustika Rustika: Data curation, Validation, Supervision. Armedy Ronny Hasugian: Data curation, Validation, Supervision. Harimat Hendarwan: Supervision. Funding This study was funded by PT Bio Farma (Persero). Data Availability Available with restricted access: The data supporting the findings of this study are available from the corresponding author upon reasonable request, in accordance with applicable data protection regulations and without compromising participant confidentiality. Declarations Ethics Approval and Consent to Participate The study was approved by the National Research and Innovation Agency’s Ethical Committee under number 163/KE.03/SK/08/2024 and was conducted in accordance with the principles of the Declaration of Helsinki. Each participant provided written informed consent. Before leaving for Saudi Arabia, the participants were informed about the study in a socialization gathering. Participants completed an online informed consent form and questionnaire two days before returning to Indonesia. The research team re-inquired at the health quarantine office to ensure the participants understood the study. They signed a paper-informed consent form. Participants under 18 years provided informed assent with signs from parents or guardians. Competing Interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1. Supplementary Material 2. Data Availability Statement Available with restricted access: The data supporting the findings of this study are available from the corresponding author upon reasonable request, in accordance with applicable data protection regulations and without compromising participant confidentiality.